The impact of 68Ga-DOTATOC positron emission tomography/computed tomography on the multimodal management of patients with neuroendocrine tumors
Standard
The impact of 68Ga-DOTATOC positron emission tomography/computed tomography on the multimodal management of patients with neuroendocrine tumors. / Frilling, Andrea; Sotiropoulos, Georgios C; Radtke, Arnold; Malago, Massimo; Bockisch, Andreas; Kuehl, Hilmar; Li, Jun; Broelsch, Christoph E.
in: ANN SURG, Jahrgang 252, Nr. 5, 5, 11.2010, S. 850-856.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - The impact of 68Ga-DOTATOC positron emission tomography/computed tomography on the multimodal management of patients with neuroendocrine tumors
AU - Frilling, Andrea
AU - Sotiropoulos, Georgios C
AU - Radtke, Arnold
AU - Malago, Massimo
AU - Bockisch, Andreas
AU - Kuehl, Hilmar
AU - Li, Jun
AU - Broelsch, Christoph E
PY - 2010/11
Y1 - 2010/11
N2 - To evaluate the impact of 68Ga-DOTATOC positron emission tomography (PET)/computed tomography (CT) on the multimodal management of neuroendocrine tumors (NET).
AB - To evaluate the impact of 68Ga-DOTATOC positron emission tomography (PET)/computed tomography (CT) on the multimodal management of neuroendocrine tumors (NET).
KW - Adult
KW - Humans
KW - Male
KW - Aged
KW - Female
KW - Middle Aged
KW - Sensitivity and Specificity
KW - Disease Progression
KW - Magnetic Resonance Imaging
KW - Neoplasm Staging
KW - Whole Body Imaging
KW - Tomography, X-Ray Computed/methods
KW - Positron-Emission Tomography/methods
KW - Radiopharmaceuticals/diagnostic use
KW - Gallium Radioisotopes
KW - Neuroendocrine Tumors/pathology/radiography/radionuclide imaging
KW - Octreotide/analogs & derivatives/diagnostic use
KW - Adult
KW - Humans
KW - Male
KW - Aged
KW - Female
KW - Middle Aged
KW - Sensitivity and Specificity
KW - Disease Progression
KW - Magnetic Resonance Imaging
KW - Neoplasm Staging
KW - Whole Body Imaging
KW - Tomography, X-Ray Computed/methods
KW - Positron-Emission Tomography/methods
KW - Radiopharmaceuticals/diagnostic use
KW - Gallium Radioisotopes
KW - Neuroendocrine Tumors/pathology/radiography/radionuclide imaging
KW - Octreotide/analogs & derivatives/diagnostic use
U2 - 10.1097/SLA.0b013e3181fd37e8
DO - 10.1097/SLA.0b013e3181fd37e8
M3 - SCORING: Journal article
C2 - 21037441
VL - 252
SP - 850
EP - 856
JO - ANN SURG
JF - ANN SURG
SN - 0003-4932
IS - 5
M1 - 5
ER -